European Infant Neuroblastoma Study Group - 1999 Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
1999
NCT00025623
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now